BioSpace News Archive

FDA

FDA Approves Trevena’s IV Opioid Olinvyk for Short-Term Acute Pain Management

Olinvyk is indicated for short-term intravenous use in hospitals or other controlled clinical settings, such as during inpatient and outpatient procedures.

August 13, 2020
·
2 min read
·
Alex Keown
Biotech Beach

Using Machine Learning to ID Potential COVID-19 Treatments

Researchers at the University of California, Riverside leveraged machine learning to screen more than 10 million commercially available small molecules for interactions with SARS-CoV-2 viral proteins, and found hundreds of drugs that might offer treatments against COVID-19.

August 13, 2020
·
3 min read
·
Mark Terry
Business

Clinical Transparency Proponents Question Safety and Efficacy of Russia’s COVID-19 Vaccine

While Russian President Vladimir Putin expressed confidence in the preventative medication against the novel coronavirus, scientists from across the globe expressed concern over the lack of available data.

August 13, 2020
·
4 min read
·
Alex Keown
FDA

FDA Approves NS Pharma’s Viltepso for Duchenne Muscular Dystrophy

The U.S. Food and Drug Administration (FDA) approved another therapy for Duchenne muscular dystrophy (DMD), this time NS Pharma’s Viltepso (viltolarsen).

August 13, 2020
·
3 min read
·
Mark Terry
Gut Enzymes Show Promise in Helping to Identify Potential Diseases

According to a study published in Nature Communications on August 11, enzymes that are used by bacteria to break down mucus in the gut can potentially be useful biomarkers for intestinal diseases.

August 13, 2020
·
3 min read
·
Krystle Vermes
Career Advice

How to Write a Great Interview Follow up Email

Writing a interview follow up email that expresses your enthusiasm and competence for the available role can help you stand out. Let’s check how to write one.

August 13, 2020
·
2 min read
·
Laura Brothers
Policy

Passage Bio’s Gene Therapy for GM1 Gangliosidosis Hit with Clinical Hold

Passage Bio’s first attempt to develop a GM1 gangliosidosis gene therapy treatment has run into a roadblock in the form of a clinical hold.

August 13, 2020
·
2 min read
·
Alex Keown
Biotech Bay

Mission Bio Secures $70 Million to Expand Development of Tapestri Platform

Mission Bio’s Tapestri Platform is the first-ever single-cell multi-omics platform capable of identifying cancer cell mutation profiles.

August 13, 2020
·
2 min read
·
Alex Keown
Drug Development

American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure

American Gene Technologies (AGT), based in Rockville, Maryland, received the go-ahead from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial of AGT103-T, a gene therapy, to eliminate HIV from infected individuals.

August 13, 2020
·
4 min read
·
Mark Terry
Biotech Bay

Research Roundup: How the COVID-19 Virus Infects Other Cells and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

August 13, 2020
·
5 min read
·
Mark Terry